Beyond Air (XAIR) Convertible Debt (2015 - 2016)
Beyond Air recorded quarterly Convertible Debt of $2.9 million in Q4 2016, up 86.53% quarter-over-quarter from $1.6 million in Q4 2015, and up 86.53% year-over-year from $1.6 million in Q1 2016.
Beyond Air's Convertible Debt history runs 2 years deep, the most recent figure standing at $2.9 million for Q4 2016.
- In Q4 2016, Convertible Debt rose 86.53% year-over-year to $2.9 million; the TTM figure through Dec 2016 stood at $2.9 million (up 86.53% YoY), while the FY2016 annual figure was $2.9 million, up 86.53% from the prior year.
- Convertible Debt came in at $2.9 million for Q4 2016 at Beyond Air, up from $1.6 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $2.9 million in Q4 2016 to a low of $1.6 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 2.90 Mn |
| Dec 31, 2015 | 1.55 Mn |